Funding for innovative projects on stem cells and aging
Official title: Pilot Projects Program
Funded at Rhode Island Hospital · NIH-10874453 · Data updated 2026-11-12
This program is helping new researchers explore how stem cells can improve our understanding of aging and develop new treatments, while also supporting diverse students in the field.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $195,186 |
| NIH project number | 5P30GM145500-02 |
| Project ID | NIH-10874453 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include older adults and individuals interested in advancements in regenerative medicine and aging.
✕Less likely to help
Patients with conditions unrelated to aging or stem cell therapies may not receive direct benefits from this research.
What this research studies
This program aims to support early-stage researchers in the field of stem cells and aging by providing funding for pilot projects that translate basic research into clinical applications. It will select promising research teams and offer mentorship from experienced investigators to help them develop their projects. The program also emphasizes diversity by providing summer stipends for students from under-represented groups. Overall, it seeks to enhance the understanding of aging and regenerative medicine through collaborative research efforts.
Why it matters
Potential benefit: If successful, this research could lead to new treatments and therapies for age-related diseases, improving the quality of life for older adults.
How similar studies have gone: Previous research in stem cell therapies and aging has shown promising results, indicating that this approach has potential for significant advancements.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Dubielecka-Szczerba, Patrycja Marta — Rhode Island Hospital
- Study coordinator: Dubielecka-Szczerba, Patrycja Marta
Related research
Other NIH-funded projects on the same topics.
-
How often to treat schistosomiasis to protect the liver
A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.
-
Technology-assisted overdose response tools for Rhode Island communities
A Rhode Island hospital-led project will test easy-to-use, tech-enabled tools (like wall buttons, wearable sensors, and a mobile app) to help detect and respond to overdoses in real-world settings.
-
Mindfulness training to lower cardiovascular risk for moms and babies during pregnancy
A mindfulness program is being tested during pregnancy to help prevent high blood pressure and heart problems for mothers and their babies.
-
Point-of-care test to spot risk of liver scarring from Schistosoma japonicum
This project aims to develop a simple clinic test to find people with S. japonicum infection who are likely to develop worsening liver scarring so they can get treatment earlier.
-
Mobile phone-based screening for anemia in young children in western Kenya
A low-cost, phone-based screening approach helps identify anemia in young children in western Kenya so they can get timely care.
-
Role of lactate transporters in lung scarring
Aims to see if blocking lactate transporters can slow or stop scar-forming cells from thickening the lungs in people with fibrotic lung disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.